Perrigo Company plc PRGO
16.55 USD -0.28 (-1.66%)
At closeNov 11, 2026, 4:11 PM EST
16.57 +0.02 +0.11%
After hours · Nov 11, 4:11 PM ET
16.38 Day range 16.72
9.23 52-week range 17.02
- YTD
- +18.89%
- 1 year
- +15.73%
News
prnewswire.com Perrigo to Attend the Jefferies Miami Consumer Conference DUBLIN, Nov. 11, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care products, today announced that Interim President and CEO Albert Manzone and CFO…
benzinga.com Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields Healthcare dividend stocks PRGO (7.32%), BMY (4.06%) and GSK (3.65%) feature analyst ratings and recent company news.
marketbeat.com Perrigo Q3 Earnings Call Highlights Perrigo NYSE: PRGO reported lower third-quarter sales and earnings as cautious retailer inventory decisions and weakness in Europe weighed on results, even as the self-care company gained market…
fool.com Perrigo: 3 Key Takeaways for Long-Term Investors Perrigo agreed to divest its infant formula business. U.S. e-commerce reached 22% of Perrigo's U.S. volume.
seekingalpha.com Perrigo Company plc (PRGO) Q3 2026 Earnings Call Transcript Perrigo Company plc ( PRGO ) Q3 2026 Earnings Call November 4, 2026 8:30 AM EST Company Participants Eric Jacobson - Vice President of Global Investor Relations Albert Manzone - Interim President,…
zacks.com Perrigo (PRGO) Reports Q3 Earnings: What Key Metrics Have to Say The headline numbers for Perrigo (PRGO) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street…
benzinga.com Perrigo Q3 2026 Earnings Call Transcript Perrigo (NYSE:PRGO) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
zacks.com Perrigo (PRGO) Surpasses Q3 Earnings Estimates Perrigo (PRGO) came out with quarterly earnings of $0.6 per share, beating the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $0.8 per share a year ago.
benzinga.com Perrigo Narrows FY2026 Adj EPS Guidance from $2.25-$2.55 to $2.25-$2.45 vs $2.18 Est; Lowers FY2026 Sales Guidance from $4.019B-$4.189B to $4.011B-$4.057B vs $4.054B Est Perrigo (NYSE:PRGO) narrows FY2026 Adj EPS guidance from $2.25-$2.55 to $2.25-$2.45 vs $2.18 analyst estimate. Lowers FY2026 sales outlook from $4.019 billion-$4.189 billion to $4.011 billion-$4.057…
benzinga.com Perrigo Q3 Adj. EPS $0.60 Beats $0.50 Estimate, Sales $989.000M Beat $987.200M Estimate Perrigo (NYSE:PRGO) reported quarterly earnings of $0.60 per share which beat the analyst consensus estimate of $0.50 by 20 percent. This is a 25 percent decrease over earnings of $0.80 per share…
prnewswire.com Perrigo Reports Third Quarter 2026 Financial Results From Continuing Operations Execution of Three-S plan driving sequential improvement in operating results and market share gains across U.S. Store Brand OTC and key European brands Infant Formula divestiture expected to…
benzinga.com Canaccord Genuity Maintains Buy on Perrigo, Raises Price Target to $19 Canaccord Genuity analyst Susan Anderson maintains Perrigo (NYSE:PRGO) with a Buy and raises the price target from $17 to $19.
prnewswire.com Perrigo Announces Quarterly Dividend DUBLIN, Oct. 29, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care products, today announced that its Board of Directors has approved a quarterly…
benzinga.com Perrigo To Sell Infant Formula Business To MeridianMade For Up To $175M; Co To Refocus On Consumer Self-Care Products Advances Streamline pillar of Perrigo's Three-S plan through portfolio simplificationFurthers Perrigo's evolution into a simpler, more focused consumer self-care companyExpected to enhance Perrigo's
prnewswire.com Perrigo Announces Agreement to Divest Infant Formula Business to MeridianMade Advances Streamline pillar of Perrigo's Three-S plan through portfolio simplification Furthers Perrigo's evolution into a simpler, more focused consumer self-care company Expected to enhance…
zacks.com Earnings Preview: Perrigo (PRGO) Q3 Earnings Expected to Decline Perrigo (PRGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
benzinga.com Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields Analysts highlight high-yield healthcare stocks Perrigo (7.09%), Pfizer (5.65%) and CVS Health (2.82%), with updated ratings and news.
prnewswire.com Perrigo to Release Third Quarter 2026 Financial Results on November 4, 2026 DUBLIN, Oct. 21, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care products, today announced that it plans to release its third quarter 2026 financial…
gurufocus.com Perrigo Co PLC (PRGO) Stock Up 3.9% and Still Undervalued -- GF Score: 60/100 On October 09, 2026, Perrigo Co PLC (PRGO) shares rose by 3.9%, bringing the current price to $15.06. This movement is notable within the context of its 52-week
zacks.com Perrigo (PRGO) Moves 6.1% Higher: Will This Strength Last? Perrigo (PRGO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the…
defenseworld.net Squarepoint Ops LLC Cuts Position in Perrigo Company plc $PRGO Squarepoint Ops LLC reduced its stake in shares of Perrigo Company plc (NYSE: PRGO) by 95.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and…
zacks.com Perrigo (PRGO) Up 13.8% Since Last Earnings Report: Can It Continue? Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock?
prnewswire.com Perrigo to Attend the Barclays Global Consumer Conference DUBLIN, Aug. 27, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care products, today announced that Interim President and CEO Albert Manzone and CFO…
zacks.com PRGO or NEOG: Which Is the Better Value Stock Right Now? Investors with an interest in Medical - Products stocks have likely encountered both Perrigo (PRGO) and Neogen (NEOG). But which of these two stocks is more attractive to value investors?
zacks.com Should Value Investors Buy Perrigo (PRGO) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the…
benzinga.com Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields Benzinga readers can review the latest analyst takes on high-yielding stocks in health care sector. Top analysts & recent news on PRGO, PFE, BMY.
seekingalpha.com My Top 5 Dividend Picks For August I present my August top 5 dividend picks: PRGO, MZTI, NEE, TROW, and VICI, all rated Buy or Strong Buy for rising income and appreciation. Each pick trades at a significant discount to fair value…
seekingalpha.com Perrigo: The Rebound Is Just Getting Started Perrigo Company remains substantially undervalued, with a Buy rating justified by strong income and growth potential. Recent quarterly EPS and revenue beats, coupled with market share gains, signal…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers Zhengye Biotechnology (NASDAQ:ZYBT) stock increased by 107.0% to $2.65 during Wednesday's regular session. The company's market cap stands at $60.6 million. Bluejay Diagnostics (NASDAQ:BJDX)…
benzinga.com Wynn Resorts Posts Upbeat Q2 Earnings, Joins Bloomin' Brands, Shopify, Owens Corning And Other Big Stocks Moving Higher On Wednesday US stocks rise, Wynn Resorts beat earnings expectations, share price jumps 10.9%. Other companies recording gains in today's session.- benzinga.com Perrigo Affirms FY2026 Adj EPS Guidance of $2.25-$2.55 vs $2.11 Est; Affirms FY2026 Sales Guidance of $4.019B-$4.189B vs $4.056B Est Perrigo (NYSE:PRGO) affirms FY2026 Adj EPS guidance from $2.25-$2.55 to $2.25-$2.55 vs $2.11 analyst estimate. Affirms FY2026 sales outlook from $4.019 billion-$4.189 billion to $4.019 billion-$4.189…
benzinga.com Perrigo Q2 Adj. EPS $0.50 Beats $0.34 Estimate, Sales $1.023B Beat $1.013B Estimate Perrigo (NYSE:PRGO) reported quarterly earnings of $0.50 per share which beat the analyst consensus estimate of $0.34 by 47.06 percent. This is a 12.28 percent decrease over earnings of $0.57 per…
benzinga.com Cramer Says Credo Technology Is 'Just So Good' — But Warns This Healthcare Name Is A 'Value Trap' Jim Cramer recommends buying Constellation Energy (CEG) as it has come down too far. ManpowerGroup (MAN) is not a great win. Credo Technology (CRDO) is good. Cramer doesn't want Perrigo (PRGO).…
benzinga.com Mission Produce Posts Downbeat Q2 Earnings, Joins Ideaya Biosciences, Perrigo And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session U.S. stock futures higher, Nasdaq up 200 points. Mission Produce (NASDAQ: AVO) shares down on weak earnings. Other stocks also down in pre-market.- benzinga.com Perrigo Appoints Albert A. Manzone Interim President, CEO, Effective Immediately, Succeeding Patrick Lockwood-Taylor; Reaffirms FY26 Guidance Perrigo Company plc (NYSE:PRGO) ("Perrigo" or the "Company"), a leading provider of Consumer Self-Care Products, today announced that its Board of Directors has appointed Albert A. Manzone, a member…
benzinga.com Earnings Scheduled For May 6, 2026 
benzinga.com Perrigo Reports Q1 2026 Results: Full Earnings Call Transcript - benzinga.com Perrigo Affirms FY2026 Adj EPS Guidance of $2.25-$2.55 vs $2.11 Est; Affirms FY2026 Sales Guidance of $4.019B-$4.189B vs $4.114B Est Perrigo (NYSE:PRGO) affirms FY2026 Adj EPS guidance from $2.25-$2.55 to $2.25-$2.55 vs $2.11 analyst estimate. Affirms FY2026 sales outlook from $4.019 billion-$4.189 billion to $4.019 billion-$4.189…
benzinga.com Perrigo Q1 Adj. EPS $0.43 Beats $0.31 Estimate, Sales $939.000M Miss $1.031B Estimate Perrigo (NYSE:PRGO) reported quarterly earnings of $0.43 per share which beat the analyst consensus estimate of $0.31 by 38.71 percent. This is a 28.33 percent decrease over earnings of $0.60 per…- benzinga.com FDA Takes Step Forward on Testosterone Therapy for Men https://www.fda.gov/news-events/press-announcements/fda-takes-step-forward-testosterone-therapy-men
benzinga.com 8 Stocks to Buy as Merger-Mania Takes Over Consolidation wave creates opportunities for patient investors. 8 sectors leading now are health, semiconductors, medical devices, and media.
benzinga.com Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields Investors turn to dividend-yielding stocks during market turbulence. Benzinga offers latest analyst ratings and news on high-yielding stocks in the health care sector, including PRGO and PFE.
benzinga.com Canaccord Genuity Maintains Buy on Perrigo, Lowers Price Target to $17 Canaccord Genuity analyst Susan Anderson maintains Perrigo (NYSE:PRGO) with a Buy and lowers the price target from $20 to $17.
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session - benzinga.com Perrigo Sees FY2026 Adj EPS $2.25-$2.55 vs $2.65 Est; Sees Sales $4.019B-$4.189B vs $4.171B Est Perrigo (NYSE:PRGO) is looking for FY2026 Adj EPS of $2.25-$2.55 vs $2.65 analyst estimate. sees sales of $4.019 billion-$4.189 billion vs $4.171 billion analyst estimate.
benzinga.com Perrigo Q4 Earnings Summary & Key Takeaways - benzinga.com Perrigo Q4 Adj. EPS $0.77 Misses $0.79 Estimate, Sales $1.138B Beat $1.102B Estimate Perrigo (NYSE:PRGO) reported quarterly earnings of $0.77 per share which missed the analyst consensus estimate of $0.79 by 3.02 percent. This is a 17.2 percent decrease over earnings of $0.93 per…
- benzinga.com Earnings Scheduled For February 26, 2026
benzinga.com Primoris Services, Casella Waste Systems, Indivior, Hawaiian Electric, LKQ, Solstice Advanced Materials, Mohawk Industries, Under Armour, Power Integrations, Perrigo, Iridium Communications, Marriott Vacations Worldwide And Insperity Added To S&P SmallCap 600 https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20251205-1480992/1480992_december2025rebalance.pdf- benzinga.com UL Solutions, Pinterest, Booz Allen Hamilton, SPX Technologies, Dycom Industries, Borgwarner And Hecla Mining Co Set To S&P MidCap 400 December 22, 2025; Comfort Systems USA, Under Armour, Power Integrations, Perrigo, Iridium Communications, Marriott Vacations Worldwide And Insperity Exit S&P MidCap 400 https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20251205-1480992/1480992_december2025rebalance.pdf